Conazol Vaginal Cream is a broad-spectrum topical antifungal formulation designed for the local treatment of vulvovaginal candidiasis (commonly known as vaginal yeast infections). Containing Miconazole Nitrate (20 mg/g or 2%), this therapeutic cream targets dermatophytes and yeast species, specifically Candida albicans, to eradicate fungal overgrowth within the vaginal mucosa and surrounding vulvar tissue.
By addressing the root fungal pathogen, Conazol effectively alleviates the localized inflammatory symptoms associated with vaginal yeast infections, including pruritus (itching), burning sensations, erythema, and abnormal thick, white vaginal discharge.
Active Ingredient & Mechanism of Action
Active Formulation
Active Ingredient: Miconazole Nitrate (20 mg per gram / 2% w/w)
Pharmacological Class: Imidazole Antifungal Derivative
Pharmacodynamic Mechanism
Miconazole nitrate exerts its antifungal activity by inhibiting the fungal cytochrome P450 enzyme 14α-demethylase. This enzyme inhibition impairs the biosynthesis of ergosterol, an essential structural component of fungal cell membranes.
Membrane Disruption: The depletion of ergosterol, combined with the accumulation of toxic methylated sterol intermediates, alters the permeability and fluidity of the fungal cell membrane.
Fungicidal Action: This cellular leakage leads to intracellular organelle damage, inhibition of fungal cell growth, and ultimate cell death (fungicidal activity).
Antibacterial Property: Miconazole also demonstrates secondary activity against certain Gram-positive bacteria (e.g., Streptococcus and Staphylococcus species), which may co-exist in mixed vaginal infections.
Key Medical Indications & Therapeutic Benefits
Targeted Candidiasis Treatment: Directly treats vaginal yeast infections caused by Candida species.
Rapid Symptom Relief: Provides rapid localized relief from severe vulvovaginal itching, burning, soreness, and irritation.
Dual Internal & External Application: Formulated for both intravaginal administration (using the included applicator) and external vulvar application to soothe external tissue discomfort.
Targeted Local Delivery: Delivers high concentration to the site of infection with minimal systemic absorption, enhancing overall safety and tolerability.
Usage Instructions & Administration Guidelines
Clinical Note: Complete the full course of treatment specified by your healthcare provider or package instructions, even if clinical symptoms disappear earlier.
Step-by-Step Administration
Preparation: Wash hands thoroughly with mild soap and water prior to handling the medication. Cleanse the external vaginal area gently and pat dry.
Applicator Loading: Attach the reusable or disposable applicator to the top of the opening of the cream tube. Squeeze the tube until the applicator plunger fills completely with the prescribed dose of cream.
Insertion: Lie on your back with knees bent toward the chest. Gently insert the filled applicator deep into the vagina as far as it goes comfortably without applying force.
Deposition: Push the plunger fully to deposit the medication into the vaginal vault. Carefully remove the applicator.
Post-Application: Wash hands thoroughly after use. If using reusable applicators, cleanse them thoroughly with warm water and mild soap after each application and allow to air dry.
Timing & Duration
Best applied at bedtime to maximize mucosal contact time and minimize leakage.
Recommended duration of therapy typically ranges from 7 to 14 consecutive days depending on clinical assessment.
Safety Precautions, Warnings & Contraindications
Contraindications
Hypersensitivity: Known allergy or hypersensitivity to miconazole, other imidazole derivatives, or any inactive excipients in the cream.
Warnings & Precautions
Pregnancy & Lactation: Use during the first trimester of pregnancy only under explicit medical supervision. Intravaginal applicators must be used with caution during pregnancy; manual insertion of vaginal suppositories or external cream application may be advised by a physician.
Latex Contraceptive Interaction: Conazol Vaginal Cream contains mineral oil or petrolatum-based bases that can damage the latex material in condoms and diaphragms, reducing their barrier efficacy. Alternative non-latex contraception or abstinence is recommended during treatment.
Oral Anticoagulants: Concomitant use with oral anticoagulants (e.g., Warfarin) can increase the anticoagulant effect and risk of bleeding due to potential systemic interaction, even with low systemic absorption. Blood clotting parameters (INR) should be monitored.
Hygiene Measures: Avoid tampons, intravaginal douching, spermicides, or other vaginal products while using this medication. Wear breathable cotton underwear to prevent moisture retention.
Adverse Effects & Side Effects
Conazol Vaginal Cream is generally well tolerated due to low systemic absorption. Localized transient side effects may occur in rare instances:
Mild localized burning, stinging, or redness upon application.
Mild pelvic cramping or vaginal irritation.
If severe skin hypersensitivity, hives, abdominal pain, or fever develops, discontinue use immediately and consult a physician.
Technical Specifications & Storage
Dosage Form: Vaginal Cream (2%)
Net Weight: 78 grams tube (supplied with applicator)
Storage Conditions: Store below 25°C (77°F) in a cool, dry place away from direct heat and sunlight. Do not freeze. Keep securely out of reach of children.
Medication
